Table 1.
Age-sex (m: male f: female) |
Symptom | Site of tumour and histology |
Treatment | Survival | |
---|---|---|---|---|---|
Shih et al. [2] | 15, m | Epigastric pain, decreased apetite, mild watery diarrhea |
Hepatic flexura of the colon/mucinous type adenocarcinoma | Palliative ileosigmoidostomy Chemo-ND* |
1 month after surgery |
Tung et al. [6] | 31 y, m | Persistent abdominal pain, vomiting Subacute intestinal obstruction |
Rectosigmoid side of colon signet ring cell carcinoma |
Radical surgical resection Chemo-ND |
ND* |
Messerini et al. [7] | 10 y, f | Subacute intestinal obstruction, recurrent vague abdominal pain |
Descending and sigmoid colon/poorly differentiating mucin secreting adenocarcinoma | Left hemicolectomy; 5 FU + Leucovorin |
8 months-recurrence free as known. No further information. |
Fu et al. [8] | 16 y, f | Abdominal pain, rectal bleeding |
Sigmoid colon/signet ring cell carcinoma | Hemicolectomy + anterior resection Chemo-ND |
ND |
Thota et al. [9] | 17 y, m | Progressive right sided abdominal pain and swelling | Ascending colon/signet ring cell carcinoma | Right colon resection + ileocolic anastomosis FOLFOX-6 |
1 year |
Ko et al. [10] | 13, m | Abdominal pain, poor apetite, abdominal fullness |
Ascending colon/signet cell carcinoma | Right hemicolectomy; 5 FU + Leucovorin Levamisole Sisplatin |
1 year, 5 months. |
Özgül et al. | 19 y, m | Persistant abdominal pain, weight loss | Sigmoid colon/signet ring cell carcinoma | Palliative colostomy FOLFOX-6 + bevacizumab |
ND |
*ND: not determined.